Cargando…
IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
Cancer vaccines exhibit specificity, effectiveness, and safety as an alternative immunotherapeutic strategy to struggle against malignant diseases, especially with the rapid development of mRNA cancer vaccines in recent years. However, how to maintain long-term immune memory after vaccination, espec...
Autores principales: | Zhao, Yue, Wei, Kongyuan, Chi, Hao, Xia, Zhijia, Li, Xiaosong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650235/ https://www.ncbi.nlm.nih.gov/pubmed/36389666 http://dx.doi.org/10.3389/fimmu.2022.1022808 |
Ejemplares similares
-
Ensemble deep learning enhanced with self-attention for predicting immunotherapeutic responses to cancers
por: Jin, Wenyi, et al.
Publicado: (2022) -
IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant
por: Bekele, Yonas, et al.
Publicado: (2021) -
IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates
por: Logerot, Sandrine, et al.
Publicado: (2021) -
Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine
por: Hao, Ling, et al.
Publicado: (2020) -
Adjuvants for Coronavirus Vaccines
por: Liang, Zhihui, et al.
Publicado: (2020)